We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+1.19%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.75%
AUM
$17.7B
AUM Growth
+$1.44B
(+8.9%)
Cap. Flow
+$1.58B
Cap. Flow
% of AUM
8.95%
Top 10 Holdings %
Top 10 Hldgs %
19.92%
Holding
1,403
New
439
Increased
358
Reduced
346
Closed
241
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$403M |
| 2 |
Walt Disney
DIS
|
+$157M |
| 3 |
CELG
Celgene Corp
CELG
|
+$141M |
| 4 |
Citigroup
C
|
+$137M |
| 5 |
Starbucks
SBUX
|
+$132M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Union Pacific
UNP
|
+$244M |
| 2 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$178M |
| 3 |
Canadian National Railway
CNI
|
+$146M |
| 4 |
AT&T
T
|
+$139M |
| 5 |
Micron Technology
MU
|
+$134M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.11% |
| 2 | Financials | 17.79% |
| 3 | Healthcare | 17.78% |
| 4 | Consumer Staples | 7.98% |
| 5 | Consumer Discretionary | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Apple
AAPL
$4.72T
| $869M | 4.91% |
27,708,288
+12,598,128
| +83% | +$403M |
|
|
2
Citigroup
C
$221B
| $402M | 2.27% |
7,280,459
+2,516,480
| +53% | +$137M |
|
3
Intel
INTC
$504B
| $390M | 2.21% |
12,835,134
+671,942
| +6% | +$21.7M |
|
4
Comcast
CMCSA
$78.3B
| $366M | 2.07% |
12,168,540
+1,240,880
| +11% | +$36.4M |
|
|
NVO
5
Novo Nordisk
NVO
$213B
| $315M | 1.78% |
11,488,242
+4,514,120
| +65% | +$127M |
|
6
Philip Morris
PM
$298B
| $254M | 1.44% |
3,171,918
+749,920
| +31% | +$61.7M |
|
7
American International
AIG
$41.4B
| $247M | 1.4% |
3,999,077
+107,669
| +3% | +$6.36M |
|
8
HCA Healthcare
HCA
$83.5B
| $235M | 1.33% |
2,585,365
+462,165
| +22% | +$37M |
|
9
Bank of America
BAC
$430B
| $234M | 1.32% |
13,761,904
+1,837,551
| +15% | +$30.3M |
|
10
Nokia
NOK
$54.3B
| $212M | 1.2% |
30,897,308
-6,631,698
| -18% | -$48.3M |
|
11
Qualcomm
QCOM
$180B
| $211M | 1.2% |
3,376,035
-960,161
| -22% | -$65.5M |
|
|
12
Walt Disney
DIS
$161B
| $177M | 1% |
1,550,241
+1,430,402
| +1,194% | +$157M |
|
|
UN
13
DELISTED
Unilever NV New York Registry Shares
UN
| $171M | 0.96% |
4,077,982
+1,327,295
| +48% | +$57.3M |
|
14
Prudential Financial
PRU
$40.9B
| $168M | 0.95% |
1,917,795
+523,856
| +38% | +$44.5M |
|
15
HP
HPQ
$22.4B
| $159M | 0.9% |
11,672,183
-657,350
| -5% | -$9.76M |
|
|
16
Starbucks
SBUX
$118B
| $159M | 0.9% |
2,956,730
+2,608,756
| +750% | +$132M |
|
|
CELG
17
DELISTED
Celgene Corp
CELG
| $158M | 0.89% |
1,362,516
+1,235,201
| +970% | +$141M |
|
18
Altria Group
MO
$120B
| $149M | 0.84% |
3,041,683
+1,203,250
| +65% | +$61M |
|
19
IBM
IBM
$195B
| $140M | 0.79% |
902,178
+27,781
| +3% | +$4.47M |
|
20
Unilever
UL
$130B
| $140M | 0.79% |
2,891,823
+229,801
| +9% | +$11.4M |
|
21
Cisco
CSCO
$444B
| $138M | 0.78% |
5,015,400
+1,501,739
| +43% | +$43.1M |
|
|
AGN
22
DELISTED
Allergan plc
AGN
| $137M | 0.78% |
452,010
+357,427
| +378% | +$107M |
|
23
Ericsson
ERIC
$30.6B
| $133M | 0.75% |
12,694,808
-1,858,008
| -13% | -$21.5M |
|
24
PepsiCo
PEP
$184B
| $132M | 0.75% |
1,418,403
+499,768
| +54% | +$47.8M |
|
25
UnitedHealth
UNH
$385B
| $132M | 0.75% |
1,082,820
+438,336
| +68% | +$51.9M |
|
Similar funds
VGA
Arrowstreet Capital's Q2 2015 Portfolio in Review
As of Q2 2015, Arrowstreet Capital held 1,403 positions worth $17.7B, up 8.9% from $16.2B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Arrowstreet Capital deployed $1.58B of net new capital in Q2 2015, opening 439 new positions and adding to 358 existing holdings. Its largest new stake was Teva Pharmaceuticals: 1,922,584 shares worth $114M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 29% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Union Pacific, an estimated $244M trimmed.
- Arrowstreet Capital's largest Q2 2015 buy was Teva Pharmaceuticals: 1,922,584 shares worth $114M.
- Arrowstreet Capital added most to Apple in Q2 2015, an estimated $403M increase.
- Arrowstreet Capital's biggest Q2 2015 reduction was Union Pacific, cutting an estimated $244M.
- Arrowstreet Capital fully exited Canadian National Railway in Q2 2015, selling an estimated $146M.
- Arrowstreet Capital's ten largest holdings make up 20% of its $17.7B portfolio in Q2 2015.
- Arrowstreet Capital opened 439 new positions and closed 241 in Q2 2015.
- Arrowstreet Capital's portfolio value rose 8.9% quarter-over-quarter to $17.7B.
Based on Arrowstreet Capital's 13F filing for Q2 2015, filed 13 Aug 2015.